Disorder, not just state of risk: Meta-analysis of functioning and quality of life in people at high risk of psychosis

British Journal of Psychiatry

Volumn 207, Issue 3, 2015, Pages 198-206

  Fusar Poli, Paolo ^a,b   Rocchetti, Matteo ^a,c   Sardella, Alberto ^a   Avila, Alessia ^a   Brandizzi, Martina ^a,d   Caverzasi, Edgardo ^c   Politi, Pierluigi ^c   Ruhrmann, Stephan ^e   McGuire, Philip ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF PAVIA   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COHORT ANALYSIS; COMORBIDITY; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FOLLOW UP; FUNCTIONAL DISEASE; FUNCTIONAL STATUS; GENETIC RISK; GLOBAL ASSESSMENT OF FUNCTIONING; HIGH RISK POPULATION; HUMAN; POSITIVE AND NEGATIVE SYNDROME SCALE; PSYCHOSIS; QUALITY CONTROL; QUALITY OF LIFE; REVIEW; RISK FACTOR; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SOCIAL AND OCCUPATIONAL FUNCTIONING ASSESSMENT SCALE; STRUCTURED INTERVIEW; SYSTEMATIC REVIEW; CASE CONTROL STUDY; FEMALE; FUNCTIONAL BEHAVIOR; MALE; META ANALYSIS; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; YOUNG ADULT;

CASE-CONTROL STUDIES; FEMALE; FUNCTIONAL BEHAVIOR, PSYCHOLOGY; HUMANS; MALE; PSYCHOTIC DISORDERS; QUALITY OF LIFE; RISK FACTORS; YOUNG ADULT;

EID: 84929519633     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.114.157115     Document Type: Review

References (91)

1. Fusar-Poli P, Borgwardt S, Bechdolf A, Addington J, Riecher-Rossler A, Schultze-Lutter F, et al. The psychosis high-risk state: a comprehensive state-of-the-art review. JAMA Psychiatry 2013; 70: 107-20.
2. Mrazek PB, Haggerty RJ, eds. Reducing Risks for Mental Disorders: Frontiers for Preventive Intervention Research. National Academies Press, 1994.
3. Fusar-Poli P, Bechdolf A, Taylor MJ, Bonoldi I, Carpenter WT, Yung AR, et al. At risk for schizophrenic or affective psychoses? A meta-analysis of DSM/ICD diagnostic outcomes in individuals at high clinical risk. Schizophr Bull 2013; 39: 923-32.
4. Stafford MR, Jackson H, Mayo-Wilson E, Morrison AP, Kendall T. Early interventions to prevent psychosis: systematic review and meta-analysis. BMJ 2013; 346: f185.
5. Van der Gaag M, Smit F, Bechdolf A, French P, Linszen DH, Yung AR, et al. Preventing a first episode of psychosis: meta-analysis of randomized controlled prevention trials of 12 month and longer-term follow-ups. Schizophr Res 2013; 149: 56-62.
6. Fusar-Poli P, Carpenter WT, Woods SW, McGlashan TH. Attenuated psychosis syndrome: ready for DSM-5.1? Annu Rev Clin Psychol 2014; 10: 155-92.
7. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (5th edn) (DSM-5). APA, 2013.
8. Woods SW, Walsh BC, Saksa JR, McGlashan TH. The case for including attenuated psychotic symptoms syndrome in DSM-5 as a psychosis risk syndrome. Schizophr Res 2010; 123: 199-207.
9. Schultze-Lutter F, Schimmelmann BG, Ruhrmann S, Michel C. 'A rose is a rose is a rose', but at-risk criteria differ. Psychopathology 2013; 46: 75-87.
10. Blumenthal-Barby JS. Psychiatry's new manual (DSM-5): ethical and conceptual dimensions. J Med Ethics 2014; 40: 531-6.
11. Addington J, Penn D, Woods SW, Addington D, Perkins DO. Social functioning in individuals at clinical high risk for psychosis. Schizophr Res 2008; 99: 119-24.
12. Simon AE, Graedel M, Cattapan-Ludewig K, Gruber K, Ballinari P, Roth B, et al. Cognitive functioning in at-risk mental states for psychosis and 2-year clinical outcome. Schizophr Res 2012; 142: 108-15.
13. Ruhrmann S, Paruch J, Bechdolf A, Pukrop R, Wagner M, Berning J, et al. Reduced subjective quality of life in persons at risk for psychosis. Acta Psychiatr Scand 2008; 117: 357-68.
14. Ruhrmann S, Paruch J, Bechdolf A, Pukrop R, Wagner M, Berning J, et al. Reduced subjective quality of life in persons at risk for psychosis. Acta Psychiatr Scand 2008; 117: 357-68.
15. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-12.
16. Rosenthal R. Meta-analysis: a review. Psychosom Med 1991; 53: 247-271.
17. Juni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 1999; 282: 1054-60.
18. Mertz D, Kim TH, Johnstone J, Lam PP, Science M, Kuster SP, et al. Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis. BMJ 2013; 347: f5061.
19. Borenstein M Hedges L, Higgins J, Rothstein H. Comprehensive Meta-Analysis Version 2. Biostat, 2005.
20. Paulson JF, Bazemore SD. Prenatal and postpartum depression in fathers and its association with maternal depression: a meta-analysis. JAMA 2010; 303: 1961-9.
21. Lipsey M, Wilson D. Practical Meta-analysis. Sage, 2000.
22. Cooper H, Hedges L, Valentine J. Handbook of Research Synthesis and Meta-Analysis. Sage, 2009.
23. Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000; 56: 455-63.
24. Castle DJ. The truth, and nothing but the truth, about early intervention in psychosis. Aust N Z J Psychiatry 2012; 46: 10-3.
25. Castle DJ. Is it appropriate to treat people at high-risk of psychosis before first onset? - no. Med J Australia 2012; 196: 557.
26. Fusar-Poli P, Meneghelli A, Valmaggia L, Allen P, Galvan F, McGuire P, et al. Duration of untreated prodromal symptoms and 12-month functional outcome of individuals at risk of psychosis. Br J Psychiatry 2009; 194: 181-2.
27. Ruhrmann S, Klosterkotter J, Bodatsch M, Nikolaides A, Julkowski D, Hilboll D, et al. Chances and risks of predicting psychosis. Eur Arch Psychiatry Clin Neurosci 2012; 262 (suppl 2): S85-90.
28. Ruhrmann S, Schultze-Lutter F, Klosterkotter J. Probably at-risk, but certainly ill - advocating the introduction of a psychosis spectrum disorder in DSM-V. Schizophr Res 2010; 120: 23-37.
29. Salokangas RK, Ruhrmann S, von Reventlow HG, Heinimaa M, Svirskis T, From T, et al. Axis I diagnoses and transition to psychosis in clinical high-risk patients EPOS project: prospective follow-up of 245 clinical high-risk outpatients in four countries. Schizophr Res 2012; 138: 192-7.
30. Fusar-Poli P, Nelson B, Valmaggia L, Yung AR, McGuire PK. Comorbid depressive and anxiety disorders in 509 individuals with an at-risk mental state: impact on psychopathology and transition to psychosis. Schizophr Bull 2014; 40: 120-31.
31. Modinos G, Allen P, Frascarelli M, Tognin S, Valmaggia L, Xenaki L, et al. Are we really mapping psychosis risk? Neuroanatomical signature of affective disorders in subjects at ultra high risk. Psychol Med 2014; 44: 3491-501.
32. Ruhrmann S, Schultze-Lutter F, Salokangas RKR, Heinimaa M, Linszen D, Dingemans P, et al. Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study. Arch Gen Psychiatry 2010; 67: 241-51.
33. Hafner H, Maurer K, Trendler G, an der Heiden W, Schmidt M, Konnecke R. Schizophrenia and depression: challenging the paradigm of two separate diseases - a controlled study of schizophrenia, depression and healthy controls. Schizophr Res 2005; 77: 11-24.
34. Mishara AL, Fusar-Poli P. The phenomenology and neurobiology of delusion formation during psychosis onset: Jaspers, Truman symptoms, and aberrant salience. Schizophr Bull 2013; 39: 278-86.
35. Fusar-Poli P, Van Os J. Lost in transition: setting the psychosis threshold in prodromal research. Acta Psychiatr Scand 2013; 127: 248-52.
36. Kempton MJ, Bonoldi I, Valmaggia L, McGuire P, Fusar-Poli P. Speed of psychosis progression in people at ultra-high clinical risk: a complementary meta-analysis. JAMA Psychiatry 2015; 72: 622-3.
37. Kaymaz N, Drukker M, Lieb R, Wittchen HU, Werbeloff N, Weiser M, et al. Do subthreshold psychotic experiences predict clinical outcomes in unselected non-help-seeking population-based samples? A systematic review and meta-analysis, enriched with new results. Psychol Med 2012; 42: 2239-53.
38. Kelleher I, Murtagh A, Molloy C, Roddy S, Clarke MC, Harley M, et al. Identification and characterization of prodromal risk syndromes in young adolescents in the community: a population-based clinical interview study. Schizophr Bull 2012; 38: 239-46.
39. Nelson B, Yuen HP, Wood SJ, Lin A, Spiliotacopoulos D, Bruxner A, et al. Long-term follow-up of a group at ultra high risk ('prodromal') for psychosis: the PACE 400 study. JAMA Psychiatry 2013; 70: 793-802.
40. Gustavsson A, Svensson M, Jacobi F, Allgulander C, Alonso J, Beghi E, et al. Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 2011; 21: 718-79.
41. Grossman LS, Harrow M, Rosen C, Faull R. Sex differences in outcome and recovery for schizophrenia and other psychotic and nonpsychotic disorders. Psychiatr Serv 2006; 57: 844-50.
42. Velthorst E, Nelson B, Wiltink S, de Haan L, Wood SJ, Lin A, et al. Transition to first episode psychosis in ultra high risk populations: does baseline functioning hold the key? Schizophr Res 2013; 143: 132-7.
43. Cannon TD, Cadenhead K, Cornblatt B, Woods SW, Addington J, Walker E, et al. Prediction of psychosis in youth at high clinical risk. Arch Gen Psychiatry 2008; 65: 28-37.
44. Velthorst E, Nieman DH, Linszen D, Becker H, de Haan L, Dingemans PM, et al. Disability in people clinically at high risk of psychosis. Br J Psychiatry 2010; 197: 278-84.
45. Thompson A, Nelson B, Yung A. Predictive validity of clinical variables in the 'at risk' for psychosis population: international comparison with results from the North American Prodrome Longitudinal Study. Schizophr Res 2011; 126: 51-7.
46. Ustun B, Kennedy C. What is 'functional impairment'? Disentangling disability from clinical significance. World Psychiatry 2009; 8: 82-5.
47. Samara MT, Engel RR, Millier A, Kandenwein J, Toumi M, Leucht S. Equipercentile linking of scales measuring functioning and symptoms: examining the GAF, SOFAS, CGI-S, and PANSS. Eur Neuropsychopharmacol 2014; 24: 1767-72.
48. Schultze-Lutter F, Michel C, Ruhrmann S, Schimmelmann BG. Prevalence and clinical significance of DSM-5 attenuated psychosis syndrome in adolescents and young adults in the general population: the Bern Epidemiological At-Risk (BEAR) Study. Schizophr Bull 2014; 40: 1499-508.
49. Wakefield JC. Wittgenstein's nightmare: why the RDoC grid needs a conceptual dimension. World Psychiatry 2014; 13: 38-40.
50. Epperson CN, Steiner M, Hartlage SA, Eriksson E, Schmidt PJ, Jones I, et al. Premenstrual dysphoric disorder: evidence for a new category for DSM-5. Am J Psychiatry 2012; 169: 465-75.
51. Wakefield JC. The DSM-5 debate over the bereavement exclusion: psychiatric diagnosis and the future of empirically supported treatment. Clin Psychol Rev 2013; 33: 825-45.
52. Hajek T, Slaney C, Garnham J, Ruzickova M, Passmore M, Alda M. Clinical correlates of current level of functioning in primary care-treated bipolar patients. Bipolar Disord 2005; 7: 286-91.
53. Schaub A, Neubauer N, Mueser KT, Engel R, Moller HJ. Neuropsychological functioning in inpatients with major depression or schizophrenia. BMC Psychiatry 2013; 13: 203.
54. Phillips KA, Quinn G, Stout RL. Functional impairment in body dysmorphic disorder: a prospective, follow-up study. J Psychiatr Res 2008; 42: 701-7.
55. Kelly MM, Dalrymple K, Zimmerman M, Phillips KA. A comparison study of body dysmorphic disorder versus social phobia. Psychiatr Res 2013; 205: 109-16.
56. Carrion RE, Goldberg TE, McLaughlin D, Auther AM, Correll CU, Cornblatt BA. Impact of neurocognition on social and role functioning in individuals at clinical high risk for psychosis. Am J Psychiatry 2011; 168: 806-13.
57. Chudleigh C, Naismith SL, Blaszczynski A, Hermens DF, Hodge MA, Hickie IB. How does social functioning in the early stages of psychosis relate to depression and social anxiety? Early Interv Psychiatry 2011; 5: 224-32.
58. Chung YS, Kang D-H, Shin NY, Yoo SY, Kwon JS. Deficit of theory of mind in individuals at ultra-high-risk for schizophrenia. Schizophr Res 2008; 99: 111-8.
59. Hui C, Morcillo C, Russo DA, Stochl J, Shelley GF, Painter M, et al. Psychiatric morbidity, functioning and quality of life in young people at clinical high risk for psychosis. Schizophr Res 2013; 148: 175-80.
60. Koren D, Reznik N, Adres M, Scheyer R, Apter A, Steinberg T, et al. Disturbances of basic self and prodromal symptoms among non-psychotic help-seeking adolescents. Psychol Med 2013; 43: 1365-76.
61. Lindgren M, Manninen M, Laajasalo T, Mustonen U, Kalska H, Suvisaari J, et al. The relationship between psychotic-like symptoms and neurocognitive performance in a general adolescent psychiatric sample. Schizophr Res 2010; 123: 77-85.
62. Niendam TA, Berzak J, Cannon TD, Bearden CE. Obsessive compulsive symptoms in the psychosis prodrome: correlates of clinical and functional outcome. Schizophr Res 2009; 108: 170-5.
63. Schlosser DA, Jacobson S, Chen Q, Sugar CA, Niendam TA, Li G, et al. Recovery from an at-risk state: clinical and functional outcomes of putatively prodromal youth who do not develop psychosis. Schizophr Bull 2012; 38: 1225-33.
64. Serrani D. Neurocognitive assessment of ultra high risk of psychosis states using the MATRICS battery (Measurement and Treatment Research to Improve Cognition in Schizophrenia). Rev Psiquiatr Clín 2011; 38: 130-4.
65. Shin YS, Kim SN, Shin NY, Jung WH, Hur JW, Byun MS, et al. Increased intra-individual variability of cognitive processing in subjects at risk mental state and schizophrenia patients. PLoS One 2013; 8: e78354.
66. Smieskova R, Fusar-Poli P, Aston J, Simon A, Bendfeldt K, Lenz C, et al. Insular volume abnormalities associated with different transition probabilities to psychosis. Psychol Med 2012; 42: 1613-25.
67. Stanford AD, Messinger J, Malaspina D, Corcoran CM. Theory of Mind in patients at clinical high risk for psychosis. Schizophr Res 2011; 131: 11-7.
68. Thompson A, Papas A, Bartholomeusz C, Allott K, Amminger GP, Nelson B, et al. Social cognition in clinical 'at risk' for psychosis and first episode psychosis populations. Schizophr Res 2012; 141: 204-9.
69. Van Rijn S, Aleman A, de Sonneville L, Sprong M, Ziermans T, Schothorst P, et al. Misattribution of facial expressions of emotion in adolescents at increased risk of psychosis: the role of inhibitory control. Psychol Med 2011; 41: 499-508.
70. Van Tricht MJ, Nieman DH, Koelman JHTM, van der Meer JN, Bour LJ, de Haan L, et al. Reduced parietal P300 amplitude is associated with an increased risk for a first psychotic episode. Biol Psychiatry 2010; 68: 642-8.
71. Woods SW, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen R, et al. Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. Schizophr Bull 2009; 35: 894-908.
72. Eastvold AD, Heaton RK, Cadenhead KS. Neurocognitive deficits in the (putative) prodrome and first episode of psychosis. Schizophr Res 2007; 93: 266-77.
73. Fulford D, Niendam TA, Floyd EG, Carter CS, Mathalon DH, Vinogradov S, et al. Symptom dimensions and functional impairment in early psychosis: more to the story than just negative symptoms. Schizophr Res 2013; 147: 125-31.
74. Niendam TA, Lesh TA, Yoon J, Westphal AJ, Hutchison N, Daniel Ragland J, et al. Impaired context processing as a potential marker of psychosis risk state. Psychiatry Res 2014; 221: 13-20.
75. Pruessner M, Iyer SN, Faridi K, Joober R, Malla AK. Stress and protective factors in individuals at ultra-high risk for psychosis, first episode psychosis and healthy controls. Schizophr Res 2011; 129: 29-35.
76. Quednow BB, Frommann I, Berning J, Kuehn KU, Maier W, Wagner M. Impaired sensorimotor gating of the acoustic startle response in the prodrome of schizophrenia. Biol Psychiatry 2008; 64: 766-73.
77. Rausch F, Eifler S, Esser A, Esslinger C, Schirmbeck F, Meyer-Lindenberg A, et al. The Early Recognition Inventory ERIraos detects at risk mental states of psychosis with high sensitivity. Compr Psychiatry 2013; 54: 1068-76.
78. Song YY, Kang JI, Kim SJ, Lee MK, Lee E, An SK. Temperament and character in individuals at ultra-high risk for psychosis and with first-episode schizophrenia: associations with psychopathology, psychosocial functioning, and aspects of psychological health. Compr Psychiatry 2013; 54: 1161-8.
79. Washida K, Takeda T, Habara T, Sato S, Oka T, Tanaka M, et al. Efficacy of second-generation antipsychotics in patients at ultra-high risk and those with first-episode or multi-episode schizophrenia. Neuropsychiatr Dis Treat 2013; 9: 861-8.
80. Kim KR, Song YY, Park JY, Lee EH, Lee M, Lee SY, et al. The relationship between psychosocial functioning and resilience and negative symptoms in individuals at ultra-high risk for psychosis. Aust N Z J Psychiatry 2013; 47: 762-71.
81. Bechdolf A, Pukrop R, Kohn D, Tschinkel S, Veith V, Schultze-Lutter F, et al. Subjective quality of life in subjects at risk for a first episode of psychosis: a comparison with first episode schizophrenia patients and healthy controls. Schizophr Res 2005; 79: 137-43.
82. Francey SM, Jackson HJ, Phillips LJ, Wood SJ, Yung AR, McGorry PD. Sustained attention in young people at high risk of psychosis does not predict transition to psychosis. Schizophr Res 2005; 79: 127-36.
83. Bearden CE, Wu KN, Caplan R, Cannon TD. Thought disorder and communication deviance as predictors of outcome in youth at clinical high risk for psychosis. J Am Acad Child Adolesc Psychiatry 2011; 50: 669-80.
84. Bechdolf A, Thompson A, Nelson B, Cotton S, Simmons MB, Amminger GP, et al. Experience of trauma and conversion to psychosis in an ultra-high-risk (prodromal) group. Acta Psychiatr Scand 2010; 121: 377-84.
85. Becker HE, Nieman DH, Wiltink S, Dingemans PM, de Fliert JRv, Velthorst E, et al. Neurocognitive functioning before and after the first psychotic episode: does psychosis result in cognitive deterioration? Psychol Med 2010; 40: 1599-606.
86. Brewer WJ, Francey SM, Wood SJ, Jackson HJ, Pantelis C, Phillips LJ, et al. Memory impairments identified in people at ultra-high risk for psychosis who later develop first-episode psychosis. Am J Psychiatry 2005; 162: 71-8.
87. Kim HS, Shin NY, Jang JH, Kim E, Shim G, Park HY, et al. Social cognition and neurocognition as predictors of conversion to psychosis in individuals at ultra-high risk. Schizophr Res 2011; 130: 170-5.
88. Koutsouleris N, Davatzikos C, Bottlender R, Patschurek-Kliche K, Scheuerecker J, Decker P, et al. Early recognition and disease prediction in the at-risk mental states for psychosis using neurocognitive pattern classification. Schizophr Bull 2012; 38: 1200-15.
89. Lam MML, Hung SF, Chen EYH. Transition to psychosis: 6-month follow-up of a Chinese high-risk group in Hong Kong. Aust N Z J Psychiatry 2006; 40: 414-20.
90. Lemos-Giraldez S, Vallina-Fernandez O, Fernandez-Iglesias P, Vallejo-Seco G, Fonseca-Pedrero E, Paino-Pineiro M, et al. Symptomatic and functional outcome in youth at ultra-high risk for psychosis: a longitudinal study. Schizophr Res 2009; 115: 121-9.
91. Ziermans TB, Schothorst PF, Sprong M, van Engeland H. Transition and remission in adolescents at ultra-high risk for psychosis. Schizophr Res 2011; 126: 58-64.